- 163P Circulating tumour (ct) DNA next generation sequencing (NGS) in UK advanced non-small cell lung cancer (aNSCLC) patients (pts)Cui W.; Milner-Watts C.; Lyons H.; Yousaf N.; Minchom A.R.; Bhosle J.; Davidson M.; Scott S.; Faull I.; Nagy R.J.; O'Brien M.E.R.; Popat S.Journal of Thoracic Oncology, 2021, 16(4S).
- Droplet digital PCR as an alternative method for detecting MET amplification in patients with non-small cell lung cancer.Su, Jun-wei; Weng, Cheng-Di; Yang, Jin-JiAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
- Utility of circulating tumor DNA for identifying genetic mutations in cholangiocarcinoma of East Asian patientsLiu, Cheng; Fu, Yiming; Xiao, Zebin; Chen, Yaru; Dai, Defeng; Cheng, Shaochen; Li, XiangAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
会议论文
Detecting driver mutations by AmoyDx 11-gene PCR with high concordance with next-generation sequencing in Chinese non-small cell lung cancer patients
20阅读
